Scribe Therapeutics, Inc.
Biotechnology company · Alameda, California, United States · Nasdaq: SCTX
Scribe Therapeutics, Inc. is a biotechnology company headquartered in Alameda, California, United States. Its shares trade on Nasdaq under the ticker SCTX. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $299,700 in total, most recently in 2019.
Scribe Therapeutics at a glance
What does Scribe Therapeutics do?
US government research funding
2 SBIR/STTR small-business research awards from US health agencies, $299,700 in total (2019).
Frequently asked questions about Scribe Therapeutics
Where is Scribe Therapeutics headquartered?
Scribe Therapeutics, Inc. is headquartered in Alameda, California, United States.
What does Scribe Therapeutics do?
Scribe Therapeutics, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is Scribe Therapeutics a public company?
Yes. Scribe Therapeutics, Inc. trades on Nasdaq under the ticker SCTX.
Similar companies
- Exelixis, Inc.Alameda, California, United States
- Santa Ana Bio, Inc.Alameda, California, United States
- Fluxion Biosciences Inc.Alameda, California, United States
- Cellfe, IncAlameda, California, United States
- Coolsystems IncAlameda, California, United States
- Andes AG, Inc.Alameda, California, United States
- Alveo Technologies Inc.Alameda, California, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences